SAGEcasts

Free Drug Could Sweeten Life for Diabetics
Tuesday, September 06, 2005
By providing free drugs called ACE inhibitors to people with diabetes, Medicare would both save money and save lives, researchers say. Even if officials don't agree, the upcoming Medicare drug benefit might at least get these valuable therapies into the hands of a few more seniors in need.
A Vote for Aging-Related Research?
Tuesday, October 12, 2004
Although Alzheimer's disease and stem-cell research are receiving extraordinary media and political attention because of the upcoming election, the real politics of aging-related research lie largely outside the current presidential race.

Wayne Rosenkrans

Dr. Wayne Rosenkrans is currently Scientific and Medical Strategy Director for External Scientific Affairs at AstraZeneca Pharmaceuticals. In that role he has responsibility for long-range strategy development supporting AstraZeneca's external scientific alliances and policy and a leading thinker on scenario analysis and early warning. He is also Vice-chairman and a member of the board of directors of Washington, DC-based health policy organization, Personalized Medicine Coalition. Dr. Rosenkrans is a recipient of the Society of Competitive Intelligence Professionals (SCIP) Fellows Award, and a former President of the Society.

Primary links

SAGEcasts

Sage Crossroads Newsletter

Wayne Rosenkrans